Dextrose 5% in 0.45% Sodium Chloride

Comprehensive Clinical Guide: Dextrose 5% in 0.45% Sodium Chloride (D5 1/2 NS)

1. Comprehensive Introduction & Overview

Dextrose 5% in 0.45% Sodium Chloride, frequently abbreviated in clinical settings as D5 1/2 NS, is a foundational intravenous (IV) fluid used extensively in hospital environments. It serves as a hypertonic solution relative to the plasma when considering its osmolarity, though its physiological behavior is complex due to the rapid metabolism of dextrose.

This solution consists of two primary components: 50 grams of dextrose (glucose) per liter and 77 milliequivalents (mEq) of sodium and 77 mEq of chloride per liter. It is classified as a maintenance intravenous fluid, bridging the gap between purely isotonic saline solutions and pure free-water solutions. It is designed to provide both caloric support through carbohydrates and electrolyte maintenance to prevent hyponatremia or dehydration in patients unable to ingest fluids orally.

Understanding the nuance of D5 1/2 NS is critical for clinicians, as it is not merely a "saline bag" but a dual-action agent that affects both serum glucose levels and fluid tonicity.

2. Technical Specifications & Mechanisms of Action

Chemical Composition

Mechanism of Action

The mechanism of D5 1/2 NS is biphasic:

1. Dextrose Component: Upon administration, the dextrose is rapidly metabolized by the body into carbon dioxide and water. This process provides approximately 170 calories per liter. Because the dextrose is consumed, the "effective" osmolarity of the solution changes once it enters the systemic circulation.
2. Sodium Chloride Component: The sodium and chloride ions remain in the extracellular fluid (ECF) space. Since the dextrose is metabolized, the solution effectively acts as a hypotonic fluid in the long term, providing free water to the intracellular space while maintaining a baseline level of sodium to prevent rapid shifts in tonicity.

Pharmacokinetics

• Absorption: Immediate bioavailability via intravenous route.
• Distribution: Distributes into the extracellular space; however, as dextrose is metabolized, water shifts into the intracellular space.
• Metabolism: Dextrose is oxidized to CO2 and H2O via the Krebs cycle.
• Excretion: Sodium and chloride are primarily excreted via the kidneys. Renal function must be adequate to handle the electrolyte load and prevent fluid overload.

3. Clinical Indications & Usage

D5 1/2 NS is indicated for patients who require maintenance fluids but have specific electrolyte or caloric requirements.

Primary Indications

• Maintenance Hydration: Used for patients who are NPO (nil per os) for extended periods and require a baseline of sodium and glucose to prevent ketosis and dehydration.
• Post-Operative Fluid Management: Frequently used in the immediate post-operative period to maintain hemodynamic stability.
• Correction of Hypovolemia: When patients present with mild dehydration, this solution provides a balance of salt and water.
• Pediatric Maintenance: Often used as a standard maintenance fluid for children, provided they have adequate renal function.

Dosage Guidelines

Dosage is highly individualized based on the patient’s clinical status, age, weight, and existing laboratory values (specifically serum sodium and glucose).

• Standard Adult Maintenance: Typically 1,500 to 2,500 mL per 24 hours, depending on insensible losses and urine output.
• Infusion Rate: Must be titrated based on central venous pressure (CVP) and pulmonary artery wedge pressure (PAWP) in critically ill patients to avoid pulmonary edema.
• Monitoring: Serum electrolytes (Na, K, Cl), blood glucose levels, and fluid intake/output (I&Os) must be monitored every 6–12 hours for stable patients, and more frequently for those in the ICU.

4. Risks, Side Effects, and Contraindications

Potential Adverse Effects

• Hyperglycemia: Particularly problematic in patients with undiagnosed diabetes or stress-induced hyperglycemia.
• Fluid Overload: Risk of congestive heart failure (CHF) or pulmonary edema if administered too rapidly.
• Hyponatremia (Iatrogenic): While the solution contains sodium, it is hypotonic relative to serum; rapid administration can lead to a dilution of existing sodium levels.
• Thrombophlebitis: Local irritation at the IV site due to the dextrose content and acidity (pH 3.5–6.5).

Contraindications

• Diabetic Ketoacidosis (DKA): Absolutely contraindicated until glucose levels are controlled, as the dextrose will exacerbate hyperglycemia.
• Hyperglycemic Hyperosmolar State (HHS): Contraindicated due to the risk of worsening hyperosmolarity.
• Severe Renal Impairment: Risk of fluid overload and electrolyte imbalance.
• Head Trauma/Increased Intracranial Pressure (ICP): Hypotonic solutions can worsen cerebral edema.

Drug Interactions

• Corticosteroids: May increase blood glucose levels, complicating the management of D5 1/2 NS.
• Insulin: Must be managed concurrently if the patient is hyperglycemic.
• Diuretics: May mask or alter the requirements for sodium replacement.

5. Pregnancy and Lactation Warnings

• Pregnancy (Category C): There are no adequate, well-controlled studies in pregnant women. D5 1/2 NS should only be used if clearly needed. High maternal glucose levels can lead to fetal hyperglycemia and hyperinsulinemia, which may result in neonatal hypoglycemia upon delivery.
• Lactation: It is not known whether this drug is excreted in human milk. Caution should be exercised when administered to a nursing woman.

6. Overdose Management

An overdose of D5 1/2 NS is essentially an overdose of fluid (hypervolemia) and/or glucose (hyperglycemia).

1. Immediate Action: Discontinue the infusion immediately.
2. Hypervolemia: Administer loop diuretics (e.g., Furosemide) if there is evidence of fluid overload or pulmonary edema.
3. Hyperglycemia: Administer rapid-acting insulin according to a sliding scale or weight-based protocol.
4. Electrolyte Correction: If hyponatremia develops due to excessive free-water administration, hypertonic saline (3% NaCl) may be required in severe, symptomatic cases (e.g., seizures).
5. Supportive Care: Monitor respiratory status, oxygen saturation, and neurological status closely.

7. Frequently Asked Questions (FAQ)

1. Why is D5 1/2 NS considered a "maintenance" fluid?

It contains both glucose (to prevent starvation ketosis) and sodium (to maintain extracellular volume), making it a balanced choice for patients who are not eating.

2. Can I use D5 1/2 NS to resuscitate a patient in shock?

No. D5 1/2 NS is not an ideal resuscitation fluid. Isotonic crystalloids like Lactated Ringer’s or 0.9% Normal Saline are preferred for rapid volume expansion.

3. Does this fluid raise blood sugar?

Yes. It contains 50 grams of dextrose per liter. In patients with diabetes or insulin resistance, this will cause a rise in blood glucose levels.

4. Is D5 1/2 NS safe for patients with high intracranial pressure (ICP)?

Generally, no. Hypotonic fluids can cause water to shift into brain cells, worsening cerebral edema.

5. What happens if this fluid is infused too quickly?

Rapid infusion can lead to fluid overload, causing peripheral edema, ascites, or life-threatening pulmonary edema.

6. Can I mix medications in a bag of D5 1/2 NS?

Compatibility must be verified. Many medications are incompatible with the acidic pH of dextrose-containing solutions. Always consult a drug compatibility chart before adding medications.

7. How often should serum electrolytes be checked?

For patients on maintenance fluids, daily electrolytes are standard; however, in critically ill patients, check every 6–8 hours.

8. Why is the pH of this solution acidic?

The dextrose is slightly acidic to ensure stability during the sterilization process.

9. What is the difference between D5 1/4 NS and D5 1/2 NS?

D5 1/4 NS (0.225% NaCl) is even more hypotonic and is primarily used in pediatrics. D5 1/2 NS is more appropriate for adults needing a higher sodium concentration.

10. Can I give this to a patient with heart failure?

Extreme caution is required. Patients with heart failure have limited ability to excrete excess fluid and sodium, making them highly susceptible to volume overload.

8. Clinical Pearls for the Specialist

• The "Dextrose Trap": Always remember that the dextrose is metabolized. If you are using this as a source of sodium for a patient with hyponatremia, you are effectively giving them free water, which may lower the serum sodium further.
• IV Site Care: Due to the dextrose content, the risk of phlebitis is higher than with plain saline. Change the IV site every 72–96 hours per institutional policy.
• Documentation: Always document the infusion rate in mL/hr and the total volume infused to ensure accurate I&O records.
• Special Populations: Always consider the patient's baseline renal function. If the kidneys cannot clear the sodium, the patient will retain water, leading to edema.

Disclaimer: This guide is for educational and informational purposes only and does not constitute medical advice. Clinical decisions should be made by licensed healthcare professionals based on individual patient assessment and institutional protocols.